Zydus Lifesciences (ZYDUSLIFE) — Financial Results

Zydus Lifesciences reported FY26 quarterly revenue of ₹75.9 billion, up 17% YoY, with net profit rising 15% to ₹15.9 billion and EBITDA margin expanding to 33.7% from 31.2% YoY. Growth was driven by strong performance in US formulations (5% QoQ), India branded formulations (15% YoY), and biosimilars, including launches of Tishtha™ and Anyra™. The company added 6 new US product approvals and launched Zycubo for Menkes disease. Management highlighted FY27 revenue growth expectations in the high teens, with India outperforming the market by 200-400 bps and international markets growing over 40% YoY. Margin expansion above 24% is anticipated, supported by operational efficiencies and commercialization of specialty products like Sentynl and Rolvedon. Capex for FY27 is guided at ₹1,500 crore, with R&D spend at ~8% of revenue.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ZYDUSLIFE ✨ Ask AI About This

About Zydus Lifesciences Limited (ZYDUSLIFE)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹1,16,114.43 Cr P/E: 25.9 ROE: 16.6% ROCE: 16.8% Div Yield: 0.09%

View full ZYDUSLIFE stock details →

📡 Get AI alerts when ZYDUSLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ZYDUSLIFE — Free

💡 Ask AI about this filing

"How does this financial results affect Zydus Lifesciences Limited's outlook?" "What did Zydus Lifesciences Limited announce on 24 May 2026?" "Is this positive or negative for ZYDUSLIFE?"

Ask AI Free →

📊 More ZYDUSLIFE filings

See all ZYDUSLIFE filings →

🔥 Also filed on 24 May 2026

SALZERELEC Salzer Electronics Limited Financial Results UNIVCABLES Universal Cables Limited Financial Results SOLARWORLD Solarworld Energy Solutions Limited Announcement UNIVCABLES Universal Cables Limited Corporate Action RISHABH Rishabh Instruments Limited Financial Results UNIVCABLES Universal Cables Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ZYDUSLIFE files new disclosures

Track ZYDUSLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ZYDUSLIFE — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd